STOCK TITAN

Redwoods Acquisition Corp Stock Price, News & Analysis

RWODR Nasdaq

Welcome to our dedicated page for Redwoods Acquisition news (Ticker: RWODR), a resource for investors and traders seeking the latest updates and insights on Redwoods Acquisition stock.

Redwoods Acquisition Corp (RWODR) is a special purpose acquisition company (SPAC) focused on identifying merger targets across multiple industries. This page provides official news and analysis related to its acquisition strategy, capital market activities, and investor communications.

Investors and analysts will find timely updates including merger announcements, regulatory filings, and corporate governance developments. All content is curated to meet strict financial reporting standards while maintaining accessibility for both professional and individual investors.

Key coverage areas include SPAC merger progress, target company evaluations, and capital structure updates. Bookmark this page for consolidated access to Redwoods Acquisition Corp's evolving position in the blank check company landscape.

Rhea-AI Summary

ANEW Medical, a biopharmaceutical tech firm focused on CNS and neurodegenerative treatments, and Redwoods Acquisition Corp (RWOD) have finalized their merger. The combined entity will trade on the Nasdaq under 'WENA' and 'WENAW'.

ANEW's CEO, Dr. Joseph Sinkule, highlighted the merger's role in accessing Nasdaq's international investors and advancing their three major platform technologies. RWOD's CEO, Jiande Chen, expressed enthusiasm for ANEW's potential in developing gene therapies for aging-related diseases.

Each ANEW share, previously trading under 'LEAS', will convert to 1/25,000th of a Merger Consideration share, with fractional shares rounded up. Key advisors included Chardan, Cyruli Shanks & Zizmor, Hunter Taubman Fischer & Li, and Loeb & Loeb.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

Redwoods Acquisition Corp. (RWOD) successfully closed its initial public offering on April 4, 2022, raising $100 million by selling 10 million units at $10 each. Each unit consists of one share, one warrant, and one right for future shares, and they began trading on Nasdaq under the symbol RWODU on March 31, 2022. Chardan managed the offering, which includes an option for underwriters to purchase an additional 1.5 million units. The funds will be utilized for potential mergers in carbon-neutral and energy storage sectors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags

FAQ

What is the current stock price of Redwoods Acquisition (RWODR)?

The current stock price of Redwoods Acquisition (RWODR) is $0.21 as of February 7, 2025.
Redwoods Acquisition Corp

Nasdaq:RWODR

RWODR Rankings

RWODR Stock Data

1.87M
Biological Products, (no Disgnostic Substances)
United States
NEW YORK